The management of ADHD and associated problems in a young person with cleidocranial dysostosis (CCD) and mild intellectual disability

Clinical Child Psychology and Psychiatry

Volumn 11, Issue 3, 2006, Pages 445-456

  Mcbrien, Hamilton ^a,d   Turk, Jeremy ^b   Letch, Nicole ^c  

^a BARNET ENFIELD AND HARINGEY MENTAL HEALTH NHS TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d Adolescent Outreach Team   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; Behavioural phenotype; Cleidocranial dysostosis; Comorbidity; Intellectual disability

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; ANAMNESIS; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CASE REPORT; CLEIDOCRANIAL DYSPLASIA; COGNITION; COMORBIDITY; DEVELOPMENTAL STAGE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE CALCULATION; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FEBRILE CONVULSION; FEMALE; GROUPS BY AGE; HEARING LOSS; HUMAN; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; LEARNING DISORDER; OTITIS MEDIA; PATIENT CARE; PATIENT MONITORING; PHENOTYPE; PSYCHOEDUCATION; SLEEP DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; WECHSLER INTELLIGENCE SCALE; WEIGHT GAIN;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CLEIDOCRANIAL DYSPLASIA; COGNITIVE THERAPY; FEMALE; HEALTH EDUCATION; HUMANS; MENTAL RETARDATION;

EID: 33746129968     PISSN: 13591045     EISSN: 14617021     Source Type: Journal    
DOI: 10.1177/1359104506059127     Document Type: Article

References (33)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual for mental disorders (4th ed.). Washington, DC: Author.
2. Bax, M. (1990). Behaviours seen in children with mucopolysaccharidoses. In Behavioural Phenotypes Abstracts and Syndrome Information. Oxford: SSBP Publications.
3. Bick, E.M. (1968). The classic: On hereditary cleidocranial dysostosis. Clinical Orthopaedics, 58, 5-7.
4. Bolton, P.F., Park, R.J., Higgins, J.N., Griffiths, P.D., & Pickles, A. (2002). Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain, 125(Pt 6), 1247-1255.
5. Clements, J., & Martin, N. (2002). The stories we can tell. In J. Clements & N. Martin, Assessing behaviours regarded as problematic for people with developmental disabilities (pp. 141-175). London: Jessica Kingsley.
6. Conners, C.K. (1969). A teacher rating scale for use in drug studies with children. American Journal of Psychiatry, 126(6), 884-888.
7. Conners, C.K. (1973). Rating scales for use in drug studies with children. Psychopharmacology Bulletin: Special Issue on Pharmacotherapy of Children, 24-84.
8. Cooper, S.C., Flaitz, C.M., Johnston, D.A., Lee, B., & Hecht, J.T. (2001). A natural history of cleidocranial dysplasia. American Journal of Medical Genetics, 104, 1-6.
9. Corbett, J. (1978). Population studies in mental retardation. In P. Graham (Ed.), Epidemiology of child psychiatry. London: Academic Press.
10. Crisco, J.J. (1990). Rate of cognitive development in young children with Williams syndrome. Clinical research, 38, 356A.
11. Dykens, E.M., Hodapp, R.M., & Finucane, B.M. (2000). Genetics and mental retardation syndromes. London: Paul H. Brookes Publishing Co.
12. Dykens, E.M., Hodapp, R.M., Walsh, K.K., & Nash, L. (1992). Profiles, correlates, and trajectories of intelligence in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1125-1130.
13. Emerson, E. (2003). Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. Journal of Intellectual Disability Research, 47, 51-58.
14. Gillberg, C., & Billstedt, E. (2000). Autism and Asperger syndrome: Coexistence with other clinical disorders. Acta Psychiatrica Scandinavica, 102(5), 321-330.
15. Handen, B.L., Breaux, A.M., Janovsky, J., McAuliffe, S., Feldman, H., & Gosling, A. (1992). Effects and noneffects of methylphenidate in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 455-461.
16. Handen, B.L., Janovsky, J., Gosling, A., Breaux, A.M., & McAuliffe, S. (1991). Adverse side effects of methylphenidate among mentally retarded children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 241-245.
17. Hill, P., & Turk, J. (1995). Attention deficit disorders and behaviouralphenotypes. Society for the Study of Behavioural Phenotypes, 4th International Symposium: Abstracts. Cambridge: SSBP.
18. Hunt, A., & Dennis, J. (1987). Psychiatric disorder among children with tuberous sclerosis, Developmental Medicine and Child Neurology, 29, 190-198.
19. Ishii, T., Takahashi, O., Kawamura, Y., & Ohta, T. (2003). Comorbidity in attention deficit-hyperactivity disorder. Psychiatry & Clinical Neurosciences, 57, 457-463.
20. Jensen, B.L. (1990). Somatic development in cleidocranial dysplasia. American Journal of Medical Genetics, 35, 69-74.
21. Klein, R.G., & Mannuzza, S. (1991). Long-term outcome of hyperactive children: A review. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 383-387.
22. Mayes, S.D., Crites, L., Bixler, E.O., Humphrey, F.J., II, & Mattison, E. (1994). Methylphenidate and ADHD: Influence of age, IQ and neurodevelopmental status. Developmental Medicine and Child Neurology, 36, 1099-1107.
23. The MTA Co-operative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
24. Mundlos, S. (1999). Cleidocranial dysplasia: Clinical and molecular genetics. Journal of Medical Genetics, 36, 177-182.
25. National Institute for Clinical Excellence. (2000). Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood. Technology Appraisal Guidance No.13.
26. Neinhaus, H., Mau, U., Zang, K.D., & Henn, W. (1995). Pericentric inversion of chromosome 6 in a patient with cleidocranial dysplasia. American Journal of Medical Genetics, 46(6), 630-631.
27. Nolan, G., & Hackman, A. (1970). Cleidocranial dysostosis: Psychological observation of two cases. British Journal of Psychiatry, 116, 543-544.
28. Rutter, M., Graham, P., & Yule, W. (1970). A neuropsychiatry study in childhood. London: Spastics International Medical Publications.
29. Swanson, J.M., McBurnett, K., Wigal, T., Pfiffner, L.J., Lerner, M.A., Williams, L., Christian, D.L., Tamm, L., Willcutt, E., Crowley, K., Clevenger, W., Khouzam, N., Woo, C., Crinella, F.M., & Fisher, T.D. (1993). Effect of stimulant medication on children with attention deficit disorder: A 'review of reviews'. Exceptional Children, 60, 154-162.
30. Turk, J. (1998). Fragile X syndrome and attentional deficits. Journal of Applied Research in Intellectual Disabilities, 11, 175-191.
31. Turk, J., & Graham, P. (1997). Fragile X syndrome, autism and autistic features. Autism, 1, 175-197.
32. Turk, J., & O'Brien, G. (2002). Counselling parents and carers of individuals with behavioural phenotypes. In G. O'Brien (Ed.), Behavioural phenotypes in clinical practice (pp. 152-168). London: MacKeith Press.
33. Turk, J., & Sales, J. (1996). Behavioural phenotypes and their relevance to child mental health professionals. Child Psychology and Psychiatry Review, 1, 4-11.